Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Immunomodulating treatment for the orphan disease Myasthenia gravis

Reference number
Coordinator TOLERANZIA AB
Funding from Vinnova SEK 500 000
Project duration April 2013 - August 2013
Status Completed

Last updated 25 November 2019

Reference number 2013-00399